Drug Watch: Agents in late-stage development for the treatment of cystic fibrosis (May 2009) (PDF)

News
Article

Agents in late-stage development for the treatment of cystic fibrosis.

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
Study Shows Staying Active Through Regular Exercise Significantly Reduces Risk Of Death With Those With ILD

Study Shows Staying Active Through Regular Exercise Significantly Reduces Risk Of Death With Those With ILD

Keith Loria
September 16th 2025
Article

Read More

Remote Care Advancement for Heart Failure, COPD and Diabetes Patients

Remote Care Advancement for Heart Failure, COPD and Diabetes Patients

Briana Contreras
September 16th 2025
Podcast

Listen

Big Beautiful Bill Reduces Drugs Eligible for Price Negotiations

Big Beautiful Bill Reduces Drugs Eligible for Price Negotiations

Denise Myshko
September 16th 2025
Article

Read More

ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain

ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain

Denise Myshko
September 16th 2025
Article

Read More

AI-Driven Tool Links Lung Fibrosis to Accelerated Aging in IPF and Aging Research

AI-Driven Tool Links Lung Fibrosis to Accelerated Aging in IPF and Aging Research

Keith Loria
September 16th 2025
Article

Read More

lung illustration in body black background | image credit:©PIC4U stock.adobe.com

Calluna Pharma Launches Phase 2 AURORA Trial of CAL101 to Halt Lung Decline in IPF Patients

Keith Loria
September 16th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.